The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Nice try TommylovestheD.
If you consider the history of the company, failed P3, £85M fund raise and 2 years have passed within nothing then you can understand why shareholders are nervous.
If RM had a track record for success then yes leave him alone. Sadly, he is in charge of a company that went from a MCAP of £230M down to £13M but OK leave him to get on with it because we trust him.
Trials are due to start in H1 subject to preparatory work and regulatory issues.
How about an update from RM saying further to our September update we are on course / in front / or behind schedule for H1 start. Not difficult however the company like to be difficult with shareholders.
The 'update' from the company in September was just waffle and the market thought the same too.
Would be good to hear about something that is actually happening as opposed to what they are hoping to do.
First thing out of the way, is this another rant from a disgruntled long term shareholder who backed the wrong horse or something else?
RM raises £85m and fails a P3 failure which reduces the share price by 97%. Add into the mix 20+ years of nothing.
2 years post P3 failure, very little progress has been made and the recovery plan has changed on several occasions.
Shareholders continue to feed off scraps.
One would have thought, this is now Richard Marsden's opportunity to get the majority of shareholders back on side and provide regular updates due the all time low share price and to acknowledge the support the company received during the £85M fund raise.
What happens?
Business as usual and very limited updates / communications. Why?
Is this because they are working on something exiting or they have nothing to share? If any of us was in the position of CEO at Synairgen, we would want share the news and provide updates because it would be the correct thing to do.
What is Marsden's problem? Does he not like his shareholders? Is he running out of ideas? Is nothing happening?
All of the above could go away with regular updates.
The silence is concerning.
Awful post from Spacman - I have a negative approach to way the company has handled many things however nothing I have seen would give rise to a claim personally against the Directors.
If the company goes bust then the administrator might have a couple of questions. Sadly I have encountered many companies go bust and lucky to receive 5 pence in the pound. Most people will take the loss and move on, nothing else can be done.
I agree with Tommy, no evidence to suggest any imminent deal. My gut feeling is that company have very little to go on and desperately need to follow through with P2 trials.
They have tried to gain traction with multiple around the world conferences, even launching their own podcast, trying to break America with the scientific conference. No such luck.
Synairgen is in a very vulnerable place:
Market has no confidence.
It appears very little interest from BP about the drug. Does it actually work?
After 20+ years of trying, Synairgen still doesn't understand where the drug sits for treating patients. This is very concerning.
If any spike in the share price, I imagine many will be looking to sell due to having little confidence in the board and the company.
Who will want to assist further fund raise after the spectacular fall of P3 failure.
Just have to sit it out again for a further 7 months and hope the P2 trials start in H1 2024.
RM has stated they will start subject to preparatory work and regulatory issues so he has given himself some further scope to extend the start date for a potential 4th time.
Share price will continue to fall and cash position weakens.
Looks like Synairgen continue to take the same approach and provide updates only when interim results and annual results are required.
It isn't interesting to us though is it? It is just another link that won't change the progress of Synairgen.
4 trades today, best kept secret or the market has had enough?